Journal: Science immunology
Article Title: Transmembrane domain–driven PD-1 dimers mediate T cell inhibition
doi: 10.1126/sciimmunol.ade6256
Figure Lengend Snippet: (A to C) Thy1.1 and PD-1 expression on reconstituted PD-1−/− OT1 CD8+ T cells after RV transduction with the indicated vector. (D to F) B16-OVA tumor growth in WT C57BL/6 mice after adoptive transfer with OT1 T cells retrovirally transduced as in (A) to (C). (D) Spider chart of tumor growth in individual mice with no T cell transfer (gray), PD-1–WT reconstituted OT1 cells (purple), or PD-1−/− EV transduced OT1 cells (black). Spider chart of tumor growth with PD-1–G172W reconstituted OT1 cells (blue) or PD-1–L186W reconstituted OT1 cells (orange). (F) Cumulative B16-OVA tumor growth as in (D) and (E) with SEM indicated by transparent shading. Representative experiment with five mice in the vehicle group and seven mice in the EV, mPD-1–WT, mPD-1–G172W, and mPD-1–L186W groups. Significance was tested by two-way ANOVA: *P < 0.05, **P < 0.01, and ***P < 0.001.
Article Snippet: Fluorescence lifetime imaging microscopy–FRET CD8a, CD80, CD86, PD-1, PD-1–V173W, and PD-1–L184W ECDs were cloned into the monomeric enhanced green fluorescent protein (mEGFP)–N1 and mCherry2-N1 plasmids (Addgene plasmids #54767 and #54517) using the Xho I and Hind III restriction sites.
Techniques: Expressing, Transduction, Plasmid Preparation, Adoptive Transfer Assay